Hohensinn Melchior

Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study.

The XEN-GGM resulted in lower IOP and a reduction in medications from baseline over 4 years of follow-up.

Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno Glaucoma Gel Microstent implantation.

Bleb appearance after XEN surgery seems to be different to classic trabeculectomy literature.

Effect of the outer stent position on efficacy after minimally invasive transscleral glaucoma gel stent implantation.

The present study demonstrates a higher efficacy achieved with lower secondary needling rates in deeper implant positions in conjunctiva after XEN-GGM.

Mid-term surgical success after transscleral ab interno glaucoma gel stent implantation.

The XEN45 implant is effective in lowering IOP and the number of IOP-lowering medications in patients with open-angle glaucoma in the mid-term.

Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: Pilot study.

Cataract surgery combined with implantation of the gelatin stent resulted in a significant reduction in IOP in eyes with OAG.